Products for Research Use Only
RegisterLogin

CDK9-IN-39

CAT: 0804-HY-176484Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-176484Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CDK9-IN-39 (1-7a-B1) is an orally active cyclin-dependent kinase 9 (CDK9) inhibitor with an IC50 of 6.51 nM. CDK9-IN-39 induces cell apoptosis by inhibiting the phosphorylation of RNA polymerase II at Ser2 and can be used for study of colorectal cancer [1].
UNSPSC
12352005
Target
Apoptosis; CDK
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Field of Research
Cancer
Smiles
O=C(NC1=CC(C2=CC=C(C=C2OC(C)C)F)=CC=N1)NC3=CC(C(N4CCN(CC4)C)=O)=CC=C3
Molecular Formula
C27H30FN5O3
Molecular Weight
491.56
References & Citations
[1]Xu J, et al. Discovery and Administration Optimization of Novel Selective CDK9 Inhibitor, 1-7a-B1, for Improved Pharmacokinetics and Antitumor Efficacy In Vivo. J Med Chem. 2025 Jun 12;68 (11) :11586-11605.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-169683CDK2-IN-39
HY-173481CDK9-IN-37
HY-130852-01CDK9-IN-11
HY-157980CDK9-IN-32
HY-155153CDK9-IN-24
HY-160171CDK9-IN-31
HY-115714-01CDK9-IN-12
HY-143585-01CDK9-IN-14
HY-179023CDK9-IN-45
HY-176736CDK9-IN-40

Alternative Products

CatalogName
T211204-01CDK9-IN-39
030081CDK9
GTR18308618CDK9-55/CDK9 Rabbit Polyclonal Antibody
GTR18187313CDK9 Antibody
BA3838-50CDK9-IN-10
BA3826-1CDK9-IN-13
BA2986-1CDK9-IN-7
BA3853-10CDK9-IN-14
T205526-01CDK9-IN-36
T201179-01CDK9-IN-35

Popular Products